Drug details
Kisqali FeMara Co-Pack (ribociclib and letrozole tablets)
type of Antineoplastics Aromatase Inhibitor, Antineoplastics CDK Inhibitors
Kisqali Femara Co-Pack (ribociclib tablets; letrozole tablets) is a co-packaged product containing a kinase inhibitor and an aromatase inhibitor indicated as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- loss of appetite,
- dark urine,
- fever,
- easy bruising,
- unusual bleeding,
- pale skin,
- lightheadedness,
- shortness of breath,
- cold hands and feet,
- tiredness,
- yellowing of the skin or eyes (jaundice),
- chest pain,
- fluttering in your chest,
- sore throat,
- burning eyes,
- skin pain,
- red or purple skin rash with blistering and peeling,
- fast or pounding heartbeats,
- sudden dizziness,
- mouth sores, and
- cough with or without mucus,
- right-sided stomach pain,
- skin sores
The following drugs are related to Kisqali FeMara Co-Pack, either as a replacement or used together:
- ExEm Foam (air polymer-type a intrauterine foam)
- Arimidex (anastrozole)
- Caelyx (pegylated liposomal doxorubicin hydrochloride injection)
- Climara (estradiol transdermal)
- Climara Pro (estradiol, levonorgestrel transdermal)
- Delestrogen (estradiol valerate)
- Depo-Estradiol (estradiol cypionate injection)
- Elestrin (estradiol gel)
- Enhertu (fam-trastuzumab deruxtecan-nxki for injection)
- Halaven Injection (eribulin mesylate)
- Femring (estradiol acetate)
- EstroGel (estradiol gel)
- Estrasorb (estradiol topical emulsion)
- Vivelle-Dot (estradiol transdermal system)
- Menostar (estradiol transdermal system)
- Estring (estradiol vaginal ring)
- Vagifem (estradiol vaginal tablets)
- Menest (estrogens)
- Herceptin Hylecta (trastuzumab and hyaluronidase-oysk injection, for subcutaneous use)
- Milprosa (progesterone vaginal system)
- Nolvadex (tamoxifen citrate)
- Ontruzant (trastuzumab-dttb for injection)
- Perjeta (pertuzumab)
- Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf injection)
- Trodelvy (sacituzumab govitecan-hziy for injection, for iv use)
- Soltamox (tamoxifen citrate)
- Talzenna (talazoparib capsules)
- Trazimera (trastuzumab-qyyp for injection)